Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Lamivudine, commonly called 3TC, is an antiretroviral medication used to prevent and treat HIV/AIDS. It is also used to treat chronic hepatitis B when other options are not possible. It is effective against both HIV-1 and HIV-2. It is typically used in combination with other antiretrovirals such as zidovudine, dolutegravir, and abacavir. Lamivudine may…
History & Applications
Explore the main themes, entities and connections around Lamivudine. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
hiv hepatitis used reverse transcriptase zidovudine side effects treatment virus resistance liver medication combination use viral include antiretroviral abacavir epivir
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Lamivudine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Lamivudine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Lamivudine | ATC code | J05AF05 (WHO) | 1.00 | infobox |
| Lamivudine | Bioavailability | 86% | 1.00 | infobox |
| Lamivudine | CAS Number | 134678-17-4 Y | 1.00 | infobox |
| Lamivudine | ChEMBL | ChEMBL141 Y | 1.00 | infobox |
| Lamivudine | ChemSpider | 66068 Y | 1.00 | infobox |
| Lamivudine | CompTox Dashboard (EPA) | DTXSID7023194 | 1.00 | infobox |
| Lamivudine | DrugBank | DB00709 Y | 1.00 | infobox |
| Lamivudine | ECHA InfoCard | 100.132.250 | 1.00 | infobox |
| Lamivudine | Elimination half-life | 5 to 7 hours | 1.00 | infobox |
| Lamivudine | Excretion | Kidney (circa 70%) | 1.00 | infobox |
| Lamivudine | Formula | C8H11N3O3S | 1.00 | infobox |
| Lamivudine | KEGG | D00353 Y | 1.00 | infobox |
| Lamivudine | Legal status | CA: ℞-only | 1.00 | infobox |
| Lamivudine | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Lamivudine | Legal status | US: ℞-only | 1.00 | infobox |
| Lamivudine | Legal status | EU: Rx-only | 1.00 | infobox |
| Lamivudine | License data | US DailyMed: Lamivudine | 1.00 | infobox |
| Lamivudine | MedlinePlus | a696011 | 1.00 | infobox |
| Lamivudine | Molar mass | 229.25 g·mol−1 | 1.00 | infobox |
| Lamivudine | NIAID ChemDB | 000388 | 1.00 | infobox |
| Lamivudine | Other names | (−)-L-2′,3′-dideoxy-3′-thiacytidine | 1.00 | infobox |
| Lamivudine | PDB ligand | 3TC (PDBe, RCSB PDB) | 1.00 | infobox |
| Lamivudine | Pregnancy category | AU: B3 | 1.00 | infobox |
| Lamivudine | Protein binding | Less than 36% | 1.00 | infobox |
| Lamivudine | PubChem CID | 60825 | 1.00 | infobox |
| Lamivudine | Routes of administration | By mouth | 1.00 | infobox |
| Lamivudine | Trade names | Epivir, Epivir-HBV, Zeffix, others | 1.00 | infobox |
| Lamivudine | UNII | 2T8Q726O95 | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.